High-yield points
- Fungal CNS infection: think immunosuppression, diabetes, shunts or endemic exposure.
- Coccidioidal meningitis:
- hydrocephalus in about 38% ;
- asymmetric or trapped compartments and many revisions (mean 4.3) ;
- lifelong azoles .
- Aspergillosis:
- voriconazole, plus neurosurgery, which is linked to better survival ;
- gross total excision did better than subtotal in immunocompetent patients, and hydrocephalus was ominous (83% mortality) .
- Mucormycosis: rhino-orbito-cerebral in about three-quarters. Amphotericin plus urgent debridement .
- Candida shunt infection: remove the shunt. Treatment failed when it was retained .
- Cryptococcus: treat the raised ICP. Shunting normalizes it .
Landmark papers
- Schwartz et al., Blood 2005: 81 patients with CNS aspergillosis treated with voriconazole. Neurosurgery was independently associated with improved survival. This established voriconazole plus surgery as the best approach .
Fungal CNS infections are uncommon but highly lethal. Who gets them divides into three groups:
- immunocompromised children: leukemia, stem cell transplant, poorly controlled diabetes;
- children with neurosurgical hardware, especially shunts;
- otherwise healthy children in endemic areas (coccidioidomycosis).
Antifungal therapy is the backbone. The neurosurgeon's roles are:
- managing hydrocephalus;
- removing infected hardware;
- obtaining tissue;
- debulking or draining fungal abscesses and granulomas, which is associated with better survival in aspergillosis .
Coccidioidomycosis (coccidioidal meningitis)
- Epidemiology (pediatric systematic review, fluconazole era) :
- endemic in the southwestern US and northern Mexico;
- CNS involvement in 4.25% of pediatric coccidioidomycosis cases;
- hydrocephalus in 37.5% of those with CNS disease.
- Predictors :
- serum complement-fixation titers of 1:16 or higher predicted relapse or death (OR 4.5);
- lifelong azole therapy was associated with better survival (mean 82 vs 32 months).
- Hydrocephalus is hard to manage (10 children) :
- asymmetric hydrocephalus (70%), vasculitis (20%) and an isolated fourth ventricle (20%);
- a mean of 4.3 operations per child (range 1–15);
- mortality 20%;
- isolated fourth ventricle and bacterial superinfection predicted poor survival.
- Neurosurgical points (see caveats):
- expect repeated shunt revisions and multiloculated or trapped compartments;
- consider endoscopic fenestration or multiple catheters;
- an intraventricular reservoir can be used for intrathecal amphotericin in refractory disease.
- Therapy: fluconazole first line, continued lifelong .
Aspergillosis
- Who: usually hematologic malignancy or transplant patients, reached from the lungs or by spread from the paranasal sinuses through the skull base.
- Contemporary hematology cohort (89 cases) :
- Aspergillus caused 69% of CNS and sinus fungal infections, and mucormycetes 22%;
- CSF galactomannan was positive in 67% of those tested;
- 1-year survival was 32%;
- only 10% of CNS cases had neurosurgery.
- Voriconazole plus surgery (81 patients with CNS aspergillosis) :
- response rate 35% and survival 31%;
- neurosurgery (abscess resection or drainage, shunt) was independently associated with improved survival.
- Immunocompetent patients (18 patients aged 5–65) :
- often sinus- or cavernous sinus-based disease;
- mortality 44.4% overall;
- 25% after gross total excision vs 50% after subtotal;
- both biopsy-only patients died;
- hydrocephalus carried 83.3% mortality.
- Neurosurgical points:
- resect or drain accessible abscesses and granulomas ;
- a decompressive craniectomy may be needed ;
- angioinvasion causes infarcts and mycotic aneurysms (see caveats).
Mucormycosis
- Who: uncontrolled diabetes (especially ketoacidosis) and hematologic malignancy.
- Rhino-orbito-cerebral disease is the most common form, at 75.9% of 214 cases .
- Treatment: amphotericin B with surgical debridement gave the best response .
- Debridement is urgent and aggressive, often with ENT, ophthalmology and neurosurgery together (see caveats).
- Black necrotic eschar in the nose or palate, orbital apex syndrome or cavernous sinus thrombosis in a diabetic or neutropenic child is an emergency (see caveats).
Candida (shunt and device infections)
- Pediatric Candida meningitis and ventriculitis (25 children, median age 16.7 months) :
- 84% had a VP shunt;
- all had prior broad-spectrum antibiotics and neurosurgery;
- concomitant bacterial infection in 68%;
- mortality 12%.
- Treatment failed when the shunt was left in; cure needed shunt removal or revision plus systemic antifungals .
- Practical sequence: remove the hardware, place an EVD, treat until the CSF is sterile, then reimplant (see Shunt Infections).
- Neonates (prematurity, central lines) are at particular risk (see caveats).
Cryptococcus
- The main problem is raised intracranial pressure, often without ventriculomegaly.
- VP shunting (106 HIV-negative patients) :
- normalized ICP by week 4, and kept it lower than conservative management at week 12;
- cryptococcal clearance and recurrence were similar.
- Serial lumbar punctures are usually tried first (see caveats).
Related topics
- Shunt Infections: hardware removal and reimplantation.
- Management of Hydrocephalus in Bacterial and Viral Meningitis: postinfectious hydrocephalus.
- Brain Abscess in Children: abscess drainage and excision.
- Central Nervous System Tuberculosis: Neurosurgical Implications: the other chronic granulomatous meningitis.
- Epidural Abscess in Children (Intracranial and Spinal): sinus-origin intracranial infection.
- Lumbar Puncture in Children: CSF sampling and serial LPs.
- Decompressive Hemicraniectomy: step-by-step procedure.
References
- Schwartz S, Ruhnke M, Ribaud P, et al. Improved outcome in central nervous system aspergillosis, using voriconazole treatment. Blood 2005;106(8):2641–2645. doi:10.1182/blood-2005-02-0733. PMID 15998833. verified
- De la Cerda-Vargas MF, Navarro-Dominguez P, Meza-Mata E, et al. Pediatric coccidioidal meningitis: a systematic review and proportional synthesis of cases reported in the fluconazole era (2000–2025). J Fungi (Basel) 2025;11(10):713. doi:10.3390/jof11100713. PMID 41149903. verified
- De la Cerda-Vargas MF, Candelas-Rangel JA, Navarro-Dominguez P, et al. Neurococcidiomycosis in children with hydrocephalus: assessment of functional outcome, quality of life and survival in relation to neuroimaging findings. Childs Nerv Syst 2024;40(2):303–319. doi:10.1007/s00381-023-06166-x. PMID 37819508. verified
- Candoni A, Klimko N, Busca A, et al. Fungal infections of the central nervous system and paranasal sinuses in onco-haematologic patients: epidemiological study reporting the diagnostic-therapeutic approach and outcome in 89 cases. Mycoses 2019;62(3):252–260. doi:10.1111/myc.12884. PMID 30565742. verified
- Bora S, Kumar A, Mishra S, et al. Intracranial aspergillosis amongst immunocompetent patients: an experience with combined surgical and medical management of 18 patients. Clin Neurol Neurosurg 2019;186:105511. doi:10.1016/j.clineuro.2019.105511. PMID 31505434. verified
- Bonifaz A, Tirado-Sánchez A, Hernández-Medel ML, et al. Mucormycosis at a tertiary-care center in Mexico: a 35-year retrospective study of 214 cases. Mycoses 2021;64(4):372–380. doi:10.1111/myc.13222. PMID 33253454. verified
- Kılıç Çil M, Telefon AH, Eşsizoğlu P, et al. Management of pediatric Candida central nervous system infections: a retrospective analysis of a challenging case series. Childs Nerv Syst 2026;42(1). doi:10.1007/s00381-026-07222-y. PMID 41879889. verified
- Lin X, He G, Li Q, et al. Long-term outcomes of ventriculoperitoneal shunt in HIV-negative cryptococcal meningitis. Neurosurg Rev 2025;48(1):593. doi:10.1007/s10143-025-03753-1. PMID 40779175. verified
Verification (2026-11-18):
- Each reference's authors, title, journal, year, volume, pages, DOI and PMID were checked on PubMed. Reference 7 has no article number listed yet.
- Numbers were checked against the PubMed abstracts.
Caveats:
- The following are standard teaching, not drawn from the cited abstracts:
- the coccidioidal neurosurgical points (fenestration, reservoir for intrathecal amphotericin);
- infarcts and mycotic aneurysms in aspergillosis;
- the urgency and multidisciplinary nature of mucormycosis debridement and its warning signs;
- the hardware-removal sequence;
- neonatal Candida risk;
- serial lumbar punctures in cryptococcosis;
- routes of aspergillus spread (lungs, sinuses), ketoacidosis as the main mucormycosis risk, and cryptococcal raised pressure without ventriculomegaly.
- References 1, 4, 5, 6 and 8 are mostly or entirely adult.
- The figure is an original schematic.